Welcome by Dr. Gilbert Glady, President of the European Association of BioImmuneGenetic Medicine BI(G)MED) and creator of the method.
EUROPEAN ASSOCIATION OF
BIOIMMUNOGENETIC MEDICINE
About us
An International Symposium
The European Biomedicine Immuno(G)enetics Association (EBMA) is organizing the second international symposium of the BI(G)MED.
These symposia are a unique opportunity to bring together all practitioners who are interested in this innovative medical approach, whether they use it regularly with their patients, are in the process of training or are just curious to learn more.
After the success of the symposium in Krems in 2019, the beautiful city of Malaga will host this second symposium.
We wanted to make this event a moment of conviviality but also of high scientific level with internationally renowned guests
MALAGA, a destination of choice
Malaga, one of the most important cities in southern Spain, has everything you could wish for to spend a few days combining work and pleasure: sun, beach, gastronomy, culture, art, nature and a lot of happiness.
It's here!
Registration is now open!
Register now to take advantage of the Early Bird rate of 395 € before April 20th 2023.
00
Days
00
Hours
00
Minutes
00
Seconds
The speakers
Who are the stakeholders?
Calendar of events
Symposium Program
Provisional program subject to change
During this conference, a summary of recent advances and translational implications of epigenetic molecular events will be offered to understand the fundamental principles of BI(G)MED.
Prof. DAN PEER, PhD Tel Aviv UniversityPrecision nanomedicine laboratory RNA-Lipid Nanoparticles 2.0: From gene silencing to genome editing A growing body of work is highlighting genes and signaling pathways that are impaired in human disorders and that may be potential candidates for treatment. The development of nucleic acid-based tools...
Prof. Andreas Weinhaeusel, PhD University of Natural Resources and Applied Life Sciences Vienna, Austria Epigenomics FOR improving minimal invasive cancer diagnostics Related keywords: minimal invasive cancer diagnostics, biomarker development, DNA methylation, liquid biopsy The minimal invasiveness of diagnostic procedures is a prerequisite to enable broad clinical application such as early...
Prof. Peré Gascón, MD PhD Institute of Science and Technology of Barcelona, SpainSpecialty: Oncology and Hematology INTEGRATIVE ONCOLOGY: AN ONCOLOGIST’S VISION
Prof. Edward Calabrese, PhD college of public healthUniversity of Massachusetts, USA Hormesis and very high dilutions
Dr. Gilbert Glady, MD European Association for Immuno(g)enetic Biomedicine, France Dr. Narges Bahi-Jaber, PhD European Association of Immuno(G)enetic Biomedicine, France. Chronic EBV and autoimmune diseases – Standardization of serology with BI(G)MED
Presentation by different partner laboratories (TELETEST laboratory, NUGENIS laboratory and others) of new biological analyses useful in the diagnostic approach of BI(G)MED
Program coming soon
Presentation by different partner laboratories (BIOVIS laboratory, Pachmann laboratory and others) of new biological analyses useful in the diagnostic approach of BI(G)MED
Program coming soon
Our partners
Official partners
